Latest News and Press Releases

Q4 net revenue increased 14.5% to $25.3 million Q4 earnings per share grew 39% to $0.18 Provides 2013 guidance of $106-$110 million in net revenue and $0.66-$0.70 EPS MINNEAPOLIS, Feb....

MINNEAPOLIS, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 24th Annual Piper Jaffray Healthcare Conference in...

- Reprocessing of popular vein treatment catheter results in significant cost savings and medical waste reduction for vein practices - More than 350 clinics have contracted to have their...

Compression band targets hemostasis needs in rapidly-growing radial artery access for performing cardiology procedures Exclusive distribution rights to R-Band in the U.S. obtained under...

Q3 net revenues of $24.6 million Q3 earnings per share of $0.16 Provides Q4 revenue guidance of $25.0-$26.0 million and Q4 EPS guidance of $0.16-$0.17 Updates 2012 revenue guidance...

MINNEAPOLIS, Aug. 22, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 2012 Stifel Nicolaus Healthcare Conference in...

Clinical niche solution for guidewire directional control in challenging coronary and peripheral interventions, with over seven years of clinical use Transition of remaining limited inventory...

Latest addition to Vascular Solutions' SuperCross line provides a flexible tip microcatheter for use in challenging interventions Designed in response to physician requests for specific...

MINNEAPOLIS, July 31, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 32nd Annual Canaccord Genuity Growth Conference in...

Net revenue increased 11% to $24.7 million, exceeding the top end of guidance EPS increased 17% to $0.15, meeting the top end of guidance Raising 2012 revenue guidance to a range of $97.5...